145 related articles for article (PubMed ID: 34460343)
1. Drug-Related Problems on a Palliative Care Unit.
Rémi C; Bauer D; Krumm L; Bausewein C
J Pain Palliat Care Pharmacother; 2021 Dec; 35(4):264-272. PubMed ID: 34460343
[TBL] [Abstract][Full Text] [Related]
2. Drug Therapy Safety in Palliative Care-Pharmaceutical Analysis of Medication Processes in Palliative Care.
Krumm L; Bausewein C; Rémi C
Pharmacy (Basel); 2023 Oct; 11(5):. PubMed ID: 37888505
[TBL] [Abstract][Full Text] [Related]
3. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic.
Shahrami B; Sefidani Forough A; Najmeddin F; Hadidi E; Toomaj S; Javadi MR; Gholami K; Sadeghi K
J Clin Pharm Ther; 2022 Jul; 47(7):964-972. PubMed ID: 35218217
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.
Albayrak A; Başgut B; Bıkmaz GA; Karahalil B
BMC Health Serv Res; 2022 Jan; 22(1):79. PubMed ID: 35033079
[TBL] [Abstract][Full Text] [Related]
5. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
[TBL] [Abstract][Full Text] [Related]
6. Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts.
Zaal RJ; Jansen MM; Duisenberg-van Essenberg M; Tijssen CC; Roukema JA; van den Bemt PM
Int J Clin Pharm; 2013 Oct; 35(5):753-62. PubMed ID: 23715760
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia.
Sagita VA; Bahtiar A; Andrajati R
Sultan Qaboos Univ Med J; 2018 Feb; 18(1):e81-e87. PubMed ID: 29666686
[TBL] [Abstract][Full Text] [Related]
8. Drug-related problems in hospitalized patients with chronic kidney diseases and clinical pharmacist interventions.
Zhang S; Zhang GB; Huang P; Ren Y; Lin B; Shao YF; Ye XL
BMC Geriatr; 2023 Dec; 23(1):849. PubMed ID: 38093184
[TBL] [Abstract][Full Text] [Related]
9. Drug-related problems among hospitalized cancer pain patients: an investigative single-arm intervention trial.
Su YJ; Yan YD; Wang WJ; Xu T; Gu ZC; Bai YR; Lin HW
Ann Palliat Med; 2021 Feb; 10(2):2008-2017. PubMed ID: 33353357
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia.
Tan BK; Chua SS; Chen LC; Chang KM; Balashanker S; Bee PC
J Oncol Pharm Pract; 2021 Oct; 27(7):1644-1656. PubMed ID: 33040675
[TBL] [Abstract][Full Text] [Related]
11. Identification and solution of drug-related problems in the neurology unit of a tertiary hospital in China.
Liu P; Li G; Han M; Zhang C
BMC Pharmacol Toxicol; 2021 Oct; 22(1):65. PubMed ID: 34702348
[TBL] [Abstract][Full Text] [Related]
12. Characterization of drug-related problems and associated factors in ambulatory patients in China.
Wang X; Yang J; Yu X; Wang Z; Wang H; Liu L
J Clin Pharm Ther; 2020 Oct; 45(5):1058-1065. PubMed ID: 32516504
[TBL] [Abstract][Full Text] [Related]
13. Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital.
Rodrigues JPV; Marques FA; Gonçalves AMRF; Campos MSA; Reis TMD; Morelo MRS; Fontoura A; Girolineto BMP; Souza HPMC; Cazarim MS; Maduro LCDS; Pereira LRL
PLoS One; 2019; 14(1):e0210779. PubMed ID: 30657771
[TBL] [Abstract][Full Text] [Related]
14. Drug-related problems identified by clinical pharmacists in nephrology department of a tertiary hospital in China-a single center study.
Liu XX; Wang HX; Hu YY; Zhu XT; Tan X; Yang Y; Hang YF; Zhu JG
Ann Palliat Med; 2021 Aug; 10(8):8701-8708. PubMed ID: 34488359
[TBL] [Abstract][Full Text] [Related]
15. Drug related problems and pharmacist interventions in a geriatric unit employing electronic prescribing.
Raimbault-Chupin M; Spiesser-Robelet L; Guir V; Annweiler C; Beauchet O; Clerc MA; Moal F
Int J Clin Pharm; 2013 Oct; 35(5):847-53. PubMed ID: 23857430
[TBL] [Abstract][Full Text] [Related]
16. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of drug-related problems among hospitalized ischemic stroke patients in China.
Chen Q; Jin Z; Zhang P; Sun S; Li L; Liao Y
Int J Clin Pharm; 2020 Aug; 42(4):1237-1241. PubMed ID: 32607718
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams.
Blix HS; Viktil KK; Moger TA; Reikvam A
Pharm World Sci; 2006 Jun; 28(3):152-8. PubMed ID: 17004023
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the potential impact of resolving drug-related problems by clinical pharmacists in Japan: a retrospective observational study.
Oki T; Ishii S; Furukawa K; Shono A; Akazawa M
J Pharm Health Care Sci; 2021 Dec; 7(1):47. PubMed ID: 34865656
[TBL] [Abstract][Full Text] [Related]
20. Application of comprehensive pharmaceutical care program in identifying and addressing drug-related problems in hospitalized patients with osteoporosis.
Chen W; Zhang H; Jiang J; Zhang X; Ding J; Liu Y; Dang H
BMC Health Serv Res; 2022 Nov; 22(1):1438. PubMed ID: 36443812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]